GlassScriptPhysician profile
Rachel Spoonhower
NPI 1609164805
$2,511.78
in general payments reported to CMS, 2019-2025
41 companies · $665 in 2025
The $665 reported for 2025 was more than what 76% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $447 · 2022: $313 · 2023: $553 · 2024: $534 · 2025: $665.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,752.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,752.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $399.62 | 2021-2025 | |
| Novo Nordisk INC | $289.86 | 2021-2025 | Wegovy, Ozempic |
| Pfizer INC. | $231.36 | 2021-2025 | |
| Amgen INC. | $167.28 | 2021-2025 | Repatha, Otezla, Repatha |
| Glaxosmithkline, LLC. | $121.17 | 2023-2025 | Shingrix, Arexvy, Trelegy Ellipta |
| Astrazeneca Pharmaceuticals LP | $106.29 | 2021-2024 | Breztri, Airsupra |
| Lilly USA, LLC | $83.76 | 2023-2025 | Jardiance, Mounjaro |
| Dexcom, INC. | $82.57 | 2025 | Dexcom G6 Transmitter |
| Shield Therapeutics INC | $78.57 | 2024 | |
| Sanofi Pasteur INC. | $76.65 | 2022-2025 | |
| Abbott Laboratories | $68.52 | 2021-2025 | Freestyle Libre 3 |
| Exact Sciences Corporation | $59.32 | 2023 | Cologuard Collection Kit |
| Merck Sharp & Dohme LLC | $58.45 | 2021-2022 | |
| Seqirus USA INC | $57.43 | 2021-2024 | Flucelvax, Fluad |
| Corcept Therapeutics | $48.39 | 2024 | Korlym |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rachel Spoonhower listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.